Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeGlobeNewswire

      GlobeNewswire

      Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
      Biotech

      Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

      August 28, 2026
      Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results
      Technology

      Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

      August 28, 2026
      Netcapital Inc. Announces Receipt of Nasdaq Notification Regarding Delayed Annual Report on Form 10-K
      Financial

      Netcapital Inc. Announces Receipt of Nasdaq Notification Regarding Delayed Annual Report on Form 10-K

      August 28, 2026
      CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
      Health

      CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

      August 28, 2026
      GCL Announces $10 Million Share Repurchase Program
      Entertainment

      GCL Announces $10 Million Share Repurchase Program

      August 28, 2026
      Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
      Health

      Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

      August 28, 2026
      Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)
      Health

      Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)

      August 28, 2026
      Micware Group Reorganization Finalized
      Technology

      Micware Group Reorganization Finalized

      August 28, 2026
      Koss Corporation Releases Fourth Quarter and Full Year Results
      Technology

      Koss Corporation Releases Fourth Quarter and Full Year Results

      August 28, 2026
      FinVolution Group Reports Second Quarter 2026 Unaudited Financial Results
      Financial

      FinVolution Group Reports Second Quarter 2026 Unaudited Financial Results

      August 28, 2026
      « 1 … 5 6 7 8 9 … 67 »

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026